[go: up one dir, main page]

Scaravilli, 2012 - Google Patents

The neuropathology of HIV infection

Scaravilli, 2012

Document ID
2120160692845563781
Author
Scaravilli F
Publication year

External Links

Snippet

A multi-author approach is taken in this book to give a thorough view of the neuropathology of AIDS. The authors have exhaustively reviewed all the available data in order to draw a clear and complete picture of the present status. The broad approach makes the reader …
Continue reading at books.google.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus

Similar Documents

Publication Publication Date Title
Eusebio-Ponce et al. HTLV-1 infection: An emerging risk. Pathogenesis, epidemiology, diagnosis and associated diseases
Fulcher et al. Compartmentalization of human immunodeficiency virus type 1 between blood monocytes and CD4+ T cells during infection
Van Rie et al. Neurologic and neurodevelopmental manifestations of pediatric HIV/AIDS: a global perspective
Marlink Lessons from the second AIDS virus, HIV-2
Cruickshank et al. Tropical spastic paraparesis and human T cell lymphotropic virus type 1 in the United Kingdom
Lepoutre et al. Role of resident CNS cell populations in HTLV-1-associated neuroinflammatory disease
Scaravilli The neuropathology of HIV infection
Karpas Human retroviruses in leukaemia and AIDS: reflections on their discovery, biology and epidemiology
Almeida et al. Human immunodeficiency virus and the central nervous system
Feigal et al. AIDS-related cancers and their treatment
Meeker Feline immunodeficiency virus neuropathogenesis: from cats to calcium
Weiss et al. Human immunodeficiency viruses
Nascimento et al. Human T-cell leukemia virus (HTLV)-associated neuropathy
Guatelli et al. Human immunodeficiency virus
Hassounah et al. Nonhuman primates and humanized mice for studies of HIV-1 integrase inhibitors: a review
Levy The human immunodeficiency virus and its pathogenesis
Peeters Cross-species transmissions of simian retroviruses in Africa and risk for human health
Williams et al. Transfusion-transmitted retrovirus infection
Abecasis et al. Origin and distribution of HIV-1 subtypes
Baveja Diagnosis and management of HIV/AIDS: A clinician's perspective
Maurice AIDS investigators identify second retrovirus
Diallo The viral diversity in the EPIC4 cohort and the evolution of the size of the HIV-1 cellular reservoir in perinatally infected children and adolescents under cART
Harrison Neurological complications of HIV infection: clinical aspects
Lowis et al. Aids in developing countries: A comparative epidemiologic analysis
Plummer et al. COVID-19 Vaccines for HIV-Infected Patients. Viruses 2021, 13, 1890